Organogenesis' Line of Credit Round

Organogenesis raised a round of funding on April 10, 2017. Investors include Silicon Valley Bank.

Organogenesis provides wound care products for bio-active wound healing and soft tissue regeneration. The portfolio includes FDA-approved Apligraf and Dermagraft, for bio-active wound healing and laun…

Articles about Organogenesis' Line of Credit Round: